Table 2.
Mammary gland graft-site and carcinoma outcome analyses.
| Raw data from mammary gland grafting assays | ||||
|---|---|---|---|---|
| Mcs1b Donor : Recipient Genotype | ||||
| S : S | S : R | R : S R : R | ||
| Total recipients (n) | 28 | 25 | 23 | 22 |
| MG-graft positive (n) | 27 | 23 | 18 | 22 |
| MG-graft AND tumor positive (n) | 15 | 13 | 4 | 5 |
| Logistic regression of graft site mammary gland outcome | |||
|---|---|---|---|
| Effect | Coefficient | P value | Odds Ratio (95% CI) |
| Donor | 0.99 | 0.1869 | 2.69 (0.62 – 11.68) |
| Recipient | −1.31 | 0.1160 | 0.27 (0.05 – 1.38) |
| Intercept | 2.70 | 0.0004 | |
| Logistic regression of mammary gland graft site tumor outcome | |||
|---|---|---|---|
| Effect | Coefficient | P value | Odds Ratio (95% CI) |
| Donor | 1.48 | 0.0019 | 4.40 (1.73 – 11.18) |
| Recipient | −0.04 | 0.9381 | 0.96 (0.39 – 2.36) |
| Intercept | −1.22 | 0.0045 | |
Abbreviations: S, susceptible genotype; R, Mcs1b resistant genotype; n, number of females; MG, mammary gland; CI, confidence interval